San Jose, CA, United States of America

Christopher H Contag

USPTO Granted Patents = 23 

 

 

Average Co-Inventor Count = 3.2

ph-index = 13

Forward Citations = 772(Granted Patents)


Location History:

  • Mountain View, CA (US) (1997)
  • Stanford, CA (US) (2010 - 2018)
  • San Jose, CA (US) (2001 - 2024)

Company Filing History:


Years Active: 1997-2024

Loading Chart...
Loading Chart...
Loading Chart...
23 patents (USPTO):Explore Patents

Title: **Innovator Spotlight: Christopher H. Contag**

Introduction

Christopher H. Contag is a notable inventor based in San Jose, California. With an impressive portfolio of 23 patents, he has made significant contributions to the field of biotechnology and molecular biology. His innovations have had a profound impact on medical research and applications, particularly in the areas of protein regulation and extracellular vesicle targeting.

Latest Patents

Two of his most recent patents demonstrate his cutting-edge work. The first is titled "Method of Targeting Exosomes," which outlines a method of targeting extracellular vesicles that employs a molecule comprising a GLA domain. This innovation provides a pathway for manipulating extracellular vesicles for therapeutic purposes. The second patent, "Methods for Regulating Protein Function in Cells In Vivo Using Synthetic Small Molecules," describes methods and compositions for the rapid and reversible destabilization of specific proteins in live cells using cell-permeable synthetic molecules. These advancements exemplify Contag's commitment to enhancing our understanding of cellular mechanisms.

Career Highlights

Throughout his career, Christopher H. Contag has been associated with prestigious institutions such as Leland Stanford Junior University and The Board of Trustees of the Leland Stanford Junior University. His tenure at these institutions has allowed him to foster innovation and collaborate with some of the brightest minds in the field.

Collaborations

Contag has worked closely with notable colleagues, including Pamela R. Contag and David A. Benaron. Their collaborations have contributed to advancements in medical technologies and have enhanced the research landscape in their shared fields of interest.

Conclusion

Christopher H. Contag exemplifies the spirit of innovation in the biotechnology sector. With his extensive patent portfolio and collaborative efforts, he continues to pave the way for future discoveries that have the potential to revolutionize medicine and improve patient outcomes. His work not only highlights the importance of teamwork in scientific research but also showcases the impact that dedicated inventors can have on society.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…